MDMA therapy for PTSD voted down by FDA advisory panel
In a surprisingly strong rejection of the first psychedelic therapy to come before the Food and Drug Administration, a scientific advisory panel on Tuesday overwhelmingly voted against the use of MDMA for treating PTSD, putting its…
Read More...
Read More...